SARS-CoV-2感染後ギラン・バレー症候群の標的抗原探索と病態に基づく新規治療開発

• Project/Area Number: 25K19013
• Research Category: Grant-in-Aid for Early-Career Scientists
• Allocation Type: Multi-year Fund
• Review Section: Basic Section 52020:Neurology-related
• Research Institution: Chiba University
• Principal Investigator: 水地 智基 千葉大学, 医学部附属病院, 特任助教 (70788653)
• Project Period (FY): 2025-04-01 – 2027-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000); Fiscal Year 2026: ¥3,120,000 (Direct Cost: ¥2,400,000、Indirect Cost: ¥720,000); Fiscal Year 2025: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)